ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Eukaryotic Gene Expression
インパクトファクター: 1.841 5年インパクトファクター: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2018021528
pages 73-86

Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications

Nida Noreen
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Pakistan
Faqir Muhammad
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan
Bushra Akhtar
Institute of Pharmacy, Physiology, and Pharmacology, University of Agriculture, Faisalabad, Pakistan
Farooq Azam
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture Faisalabad, Pakistan
Muhammad Irfan Anwar
Faculty of Veterinary Science, Bahauddin Zakariya University, Multan, Pakistan

要約

The pharmacological importance of cannabidiol (CBD) has been in study for several years. CBD is the major nonpsychoactive constituent of plant Cannabis sativa and its administration is associated with reduced side effects. Currently, CBD is undergoing a lot of research which suggests that it has no addictive effects, good safety profile and has exhibited powerful therapeutic potential in several vital areas. It has wide spectrum of action because it acts through endocannabinoid receptors; CB1 and CB2 and it also acts on other receptors, such as GPR18, GPR55, GPR 119, 5HT1A, and TRPV2. This indicates its therapeutic value for numerous medical conditions because of its neuroprotective and immunomodulatory properties. Potential therapeutic applications of CBD include, analgesic, anti-inflammatory, anxiolytic, anti-arthritic, anti-depressant, anti-Alzheimer disease, anti-ischemic, neuroprotective, and anti-fibrotic. More promising areas appear to include diabetes and cancer where CBD exhibits lesser side effects and more therapeutic benefits as compared to recent available medical therapies. Hence, CBD is a promising substance for the development of new drug. However further research and clinical studies are required to explore its complete potential.


Articles with similar content:

Myriad Molecules to Overcome Efflux Drug Transporters and Drug-Metabolizing Enzymes: A Journey from Synthetic to Natural
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 5
Chintan Vora, Rajashree Mashru, Riddhish Patadia, Karan Mittal
Polymeric Immunonanoparticles Mediated Cancer Therapy: Versatile Nanocarriers for Cell-Specific Cargo Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 1
Niyati S. Acharya, Namdev L. Dhas, Ritu R. Kudarha, Sanjeev R. Acharya
Antiretroviral Agents: Looking for the Best Possible Chemotherapeutic Options to Conquer HIV
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 4
Tahir Farooq, Muhammad Ibrahim, Muhammad Imran Qadir, Muhammad Sajid Hamid Akash, Kanwal Rehman, Arruje Hameed
Long-Acting Injectables: Current Perspectives and Future Promise
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 2
Komal Chaudhary, Mayur M. Patel, Priti J. Mehta
Microemulsions: Applications in Transdermal and Dermal Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 6
Vandana B. Patravale, Abhijit A. Date